DOI:
10.1055/s-00000068
Seminars in Interventional Radiology
LinksClose Window
References
Newswire PR.
FDA Grants Orphan-Drug Designation for Novel Terlipressin Formulation for the Treatment of Ascites.
[updated 2013 Jan 4, cited 2013 Jun 23] Available at:
http://www.prnewswire.com/news-releases/fda-grants-orphan-drug-designation-for-novel-terlipressin-formulation-for-the-treatment-of-ascites-185655002.html . Accessed October 13, 2015
We do not assume any responsibility for the contents of the web pages of other providers.